Gender differences in the battle against COVID‐19: Impact of genetics, comorbidities, inflammation and lifestyle on differences in outcomes
Anca Pantea Stoian, Peter P. Tóth, Péter Kempler, Manfredi Rizzo
Abstract
This review has been written independently. The authors have given talks, attended conferences and participated in advisory boards and clinical trials sponsored by various pharmaceutical companies; yet, no financial or professional help was received for the preparation of this manuscript. MR is currently Director, Clinical Medical & Regulatory Department, Novo Nordisk Europe East. APS is currently Vice-President, National Diabetes Commission, Ministry of Health, Romania.
Topics & Concepts
MedicineBattleChristian ministryCoronavirus disease 2019 (COVID-19)CommissionFamily medicineGuidelineAdvisory committeeClinical trialAlternative medicineGerontologyDiseaseManagementPathologyLawInfectious disease (medical specialty)Political scienceHistoryEconomicsArchaeologyCOVID-19 Clinical Research StudiesCOVID-19 and healthcare impactsCOVID-19 Impact on Reproduction